A groundbreaking study delivers good news
We conducted a 15-year study of more than 46,000 Kaiser Permanente patients in Northern California, and found that our treatment and prevention methods are helping reduce heart attacks. The study — the first of its kind to follow a large, diverse community — showed that our treatment, which includes a low-cost, low-risk combination of medications and healthy lifestyle changes, has a positive life-changing effect.1
Innovation saving lives
Our researchers looked at if a combination of 3 prescription medications — aspirin, Lisinopril, and lipid-lowering statin (ALL) — would help prevent heart attacks and strokes. The results were promising, so we put it into practice. In 3 years, the 3-drug program reduced heart attacks and stroke by 60%.2 We've shared our findings with the health care community, and the ALL initiative has been widely adopted by other cardiac programs.
Taking research in a new direction
At a time when most cardiac studies involved middle-aged Caucasian men, we broke the mold. Our Coronary Artery Risk Development in Young Adults study (CARDIA) follows men and women who are between 18 and 30, including African-Americans and Caucasians. Looking at the relationship between lifestyle and heart health, the study has resulted in a wealth of data on how blood pressure, cholesterol, weight, and lifestyle affect heart health.
- Matthew D. Solomon, MD, PhD, et al., "Community-Based Trends in Acute Myocardial Infarction From 2008 to 2014," Journal of the American College of Cardiology, August 9, 2016, p. 666; Robert W. Yeh, MD, et al., "Population Trends in the Incidence and Outcomes of Acute Myocardial Infarction," The New England Journal of Medicine, June 10, 2010, p. 2,155.
- Internal Kaiser Permanente Northern California Department of Research study conducted from 2004–2006.